Pregnancy in rheumatic disease🤰🏻 👉🏻Pre-pregnancy counselling to explain risks & stratify 👉🏻Outcome dependent on disease activity & systemic involvement 👉🏻High-risk pregnancies need multidisciplinary care 👉🏻Many drugs have an acceptable benefit-risk profile in pregnancy #EULAR2019 https://t.co/guxXsgQoJE

RheumNow expanded twitter coverage of the #EULAR2019 annual meeting is sponsored by Horizon Pharma. All content chosen by RheumNow & its Faculty.

What do you use first line in fibromyalgia? SP0120 #EULAR2019 @RheumNow

If you can take away concomitant steroid use from Tofacitinib, can reduce zoster risk #EULAR2019 https://t.co/lifzLzqyOt

#EULAR2019. Remarkable ACR20 of 80% with Filgotinib in phase II study in PsA. https://t.co/TU5bpixE2y

Herpes and biologics and tofa #EULAR2019 https://t.co/UBr0WrV70L

#EULAR2019 Great work looking for potential biomarkers in axial #spondyloarthritis and specifically looking for tissue antigens in the sacroiliac joint. Really this is an unmet need In the filed https://t.co/k9XHUPquRr

Actually the paper says to hold MTX for 2 weeks after flu vaccine. No dose adjustments needed https://t.co/BYE0PKDoPl

• https://twitter.com/MtzReuma/status/1139511311417716740

Trial of LIVE zoster vaccine in active TNFi users -> No cases of vaccine HZ! #EULAR2019 https://t.co/tkYS5VC1yk

New concepts in FM (fibromyalgia). Diff types of pain likely warrant diff Rx. FM is nociplastic so cranial stimulation , cognitive behavioural therapy etc. Maybe that is why current Rx has low benefits such as meds S#EULAR2019 @RheumNow SP0120 https://t.co/MkqJinQe3p

In Jak we trust? #EULAR2019 https://t.co/pD0wWXtDNw

Interesting findings from an AxSpa study at the #eular2019 #rheumatology conference: spine MRIs may be used to diagnose lesions in the spine before evidence of sacroiliitis, which has diagnostic implications for early AxSpa @CreakyJoints https://t.co/rez9G7iExI

Shingrix in RA. Due to the potent immunogenicity of the adjuvant, there’s some concern it might flare RA. Study reported #EULAR2019 not showing flare. https://t.co/nrHRYdP6eN

How do we pick which scleroderma patients are stem cell transplant candidates early enough? “Patient selection is the critical thing in the whole transplant venture” - our patients have damage and aren’t as fit. Jacob van Laar at #EULAR2019 SP0113 @RheumNow https://t.co/cDuAI7iVWk

HBV reactivation with #Baricitinib use. The JAKi may causes reactivation of virus - Kevin Winthrop @OHSUNews #EULAR2019 https://t.co/phV0hVUH2Y